Ignite Creation Date:
2025-12-24 @ 12:16 PM
Ignite Modification Date:
2026-03-27 @ 8:43 AM
Study NCT ID:
NCT00098761
Status:
COMPLETED
Last Update Posted:
2011-06-30
First Post:
2004-12-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors
Sponsor:
Pediatric Brain Tumor Consortium
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Brain and Central Nervous System Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent childhood brain stem glioma | View |
| None | recurrent childhood visual pathway and hypothalamic glioma | View |
| None | recurrent childhood cerebellar astrocytoma | View |
| None | recurrent childhood cerebral astrocytoma | View |
| None | recurrent childhood ependymoma | View |
| None | recurrent childhood medulloblastoma | View |
| None | recurrent childhood supratentorial primitive neuroectodermal tumor | View |
| None | childhood central nervous system germ cell tumor | View |
| None | childhood choroid plexus tumor | View |
| None | childhood craniopharyngioma | View |
| None | childhood infratentorial ependymoma | View |
| None | childhood grade I meningioma | View |
| None | childhood grade II meningioma | View |
| None | childhood grade III meningioma | View |
| None | childhood high-grade cerebral astrocytoma | View |
| None | childhood low-grade cerebral astrocytoma | View |